Retrospective multicenter comparative study of the efficacy and safety between R-DHAC and R-DHAOx in diffuse large B-cell lymphoma or transformed follicular or marginal zone B lymphoma into aggressive lymphoma, as a second-line treatment
Leuk Lymphoma. 2024 Feb;65(2):270-274.
doi: 10.1080/10428194.2023.2281270.
Epub 2024 Jan 24.